(Q46767407)

25 December 2017

title

Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis (English)

1 reference

25 December 2017

1 reference

1 reference

7

1 reference

25 December 2017

Christopher Griffiths

8

1 reference

25 December 2017

Richard B. Warren

Richard B Warren

1

0 references

Catherine H Smith

5

Catherine H Smith

1 reference

25 December 2017

Jonathan N. Barker

6

Jonathan N W N Barker

1 reference

25 December 2017

Rhodri L L Smith

2

Rhodri L L Smith

1 reference

25 December 2017

author name string

Emanuela Campalani

3

1 reference

25 December 2017

Steve Eyre

4

1 reference

25 December 2017

language of work or name

English

0 references

publication date

7 February 2008

1 reference

25 December 2017

Journal of Investigative Dermatology

published in

1 reference

25 December 2017

volume

128

1 reference

25 December 2017

issue

8

1 reference

25 December 2017

page(s)

1925-1929

1 reference

25 December 2017

Polymorphisms in Folate, Pyrimidine, and Purine Metabolism Are Associated with Efficacy and Toxicity of Methotrexate in Psoriasis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.16

7 January 2021

Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.16

7 January 2021

Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.16

7 January 2021

Severe Psoriasis – Oral Therapy with a New Retinoid

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.16

7 January 2021

Pathogenesis and clinical features of psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.16

7 January 2021

Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.16

7 January 2021

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.16

7 January 2021

Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.16

7 January 2021

The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.16

7 January 2021

Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.16

7 January 2021

Identifiers

DOI

10.1038/JID.2008.16

1 reference

25 December 2017

release_45l764rboff6lbjwdpmnhub3wi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/45l764rboff6lbjwdpmnhub3wi

24 November 2022

mapped directly with Wikidata item

1 reference

25 December 2017